MALAT1 and heart failure: The observation that HCN channels and If currents are upregulated in the ventricular myocardium of hypertrophied and failing hearts in both rodent models and humans6–7 suggests that, in some clinical settings, ivabradine may improve the outcomes of patients with heart failure by both reducing heart rate and acting via mechanisms independent of heart rate reduction.